#MCExclusive | PharmEasy is in advanced talks to acquire diagnostics services provider Thyrocare Technologies Ltd. in a deal worth approximately Rs 7,000-cr sources with direct knowledge tell Moneycontrol.
By Nisha Poddar at
https://www.moneycontrol.com/news/business/pharmeasy-in-talks-to-buy-thyrocare-in-deal-worth-around-rs-7000-crore-7048701.html
#PharmEasy #Thyrocare #Deals
By Nisha Poddar at
https://www.moneycontrol.com/news/business/pharmeasy-in-talks-to-buy-thyrocare-in-deal-worth-around-rs-7000-crore-7048701.html
#PharmEasy #Thyrocare #Deals
Moneycontrol
Exclusive | PharmEasy in talks to buy Thyrocare for around Rs 7,000 crore
The deal is likely to be announced soon given the IPO timelines of PharmEasy’s parent, API Holdings, people with direct knowledge of the development said.
MC Newsbreak Confirmed PharmEasy parent to acquire Thyrocare as reported first by Nisha Poddar Thyrocare promoters to sell 66.1% stake, open offer for 26% at Rs 1300/sh. Deal value Thyrocare at Rs 6887 cr
https://www.moneycontrol.com/news/business/pharmeasy-to-acquire-66-1-stake-in-thyrocare-for-rs-4546-crore-7088951.html?utm_source=telegram&utm_medium=social
#pharmeasy #thyrocare #JustIn #BreakingNew
https://www.moneycontrol.com/news/business/pharmeasy-to-acquire-66-1-stake-in-thyrocare-for-rs-4546-crore-7088951.html?utm_source=telegram&utm_medium=social
#pharmeasy #thyrocare #JustIn #BreakingNew
When diagnostic laboratory chain @Thyrocare made its #IPO in 2016, its founder, Dr A Velumani, faced several questions from investors, but why?
Read more at
https://www.moneycontrol.com/news/trends/thyrocare-boss-dr-a-velumani-was-asked-to-compare-himself-to-elizabeth-holmes-theranos-7902891.html
#ElizabethHomes #Theranos #Thyrocare
Read more at
https://www.moneycontrol.com/news/trends/thyrocare-boss-dr-a-velumani-was-asked-to-compare-himself-to-elizabeth-holmes-theranos-7902891.html
#ElizabethHomes #Theranos #Thyrocare
Moneycontrol
Thyrocare boss recalls how he was asked to compare himself to fallen Silicon Valley star Elizabeth Holmes
One question that Thyrocare founder Dr A Velumani strikingly remembers compared him to Elizabeth Holmes, the fallen US biotech star, who was convicted on of defrauding investors in her blood-testing start-up Theranos.
On #MorningTrade
👉Year-end cheer missing; what’s spooking the market?
👉Renewed Covid fears driving pharma rally – Will it sustain?
👉RIL arm acquires 23% stake in US-based Exyn Technologies
👉Thyrocare, RailTel other stocks in focus
Live @ 8.30 AM
https://www.youtube.com/watch?v=tds2l7U3aVI
👉Year-end cheer missing; what’s spooking the market?
👉Renewed Covid fears driving pharma rally – Will it sustain?
👉RIL arm acquires 23% stake in US-based Exyn Technologies
👉Thyrocare, RailTel other stocks in focus
Live @ 8.30 AM
https://www.youtube.com/watch?v=tds2l7U3aVI
YouTube
Stock Market Live: Covid Fears Hurting Markets. Will The Selloff Continue? RIL, Thyrocare In Focus
Indian markets logged a third straight day of losses amid renewed Covid fears and RBI minutes that indicated that Governor Shaktikanta Das is not in favour of a pause in rate hikes just yet. Will the selloff continue as we step into the new year? Hemang Jani…